Microvasospasms After Experimental Subarachnoid Hemorrhage Do Not Depend on Endothelin A Receptors
- PMID: 29438081
- DOI: 10.1161/STROKEAHA.117.020028
Microvasospasms After Experimental Subarachnoid Hemorrhage Do Not Depend on Endothelin A Receptors
Abstract
Background and purpose: Perturbations in cerebral microcirculation (eg, microvasospasms) and reduced neurovascular communication determine outcome after subarachnoid hemorrhage (SAH). ET-1 (endothelin-1) and its receptors have been implicated in the pathophysiology of large artery spasms after SAH; however, their role in the development of microvascular dysfunction is currently unknown. Here, we investigated whether inhibiting ETA (endothelin A) receptors can reduce microvasospasms after experimentally induced SAH.
Methods: SAH was induced in male C57BL/6 mice by filament perforation of the middle cerebral artery. Three hours after SAH, a cranial window was prepared and the pial and parenchymal cerebral microcirculation was measured in vivo using two-photon microscopy before, during, and after administration of the ETA receptor inhibitor clazosentan. In separate experiments, the effect of clazosentan treatment on neurological outcome was measured 3 days after SAH.
Results: Clazosentan treatment had no effect on the number or severity of SAH-induced cerebral microvasospasms nor did it affect neurological outcome.
Conclusions: Our results indicate that ETA receptors, which mediate large artery spasms after SAH, do not seem to play a role in the development of microarterial spasms, suggesting that posthemorrhagic spasms are mediated by distinct mechanisms in large and small cerebral vessels. Given that cerebral microvessel dysfunction is a key factor for outcome after SAH, further research into the mechanisms that underlie posthemorrhagic microvasospasms is urgently needed.
Keywords: cerebrovascular circulation; endothelin-1; mice; microcirculation; subarachnoid hemorrhage.
© 2018 American Heart Association, Inc.
Similar articles
-
Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats.J Neurosurg. 2008 Dec;109(6):1134-40. doi: 10.3171/JNS.2008.109.12.1134. J Neurosurg. 2008. PMID: 19035733
-
MEK1/2 inhibitor U0126 but not endothelin receptor antagonist clazosentan reduces upregulation of cerebrovascular contractile receptors and delayed cerebral ischemia, and improves outcome after subarachnoid hemorrhage in rats.J Cereb Blood Flow Metab. 2015 Feb;35(2):329-37. doi: 10.1038/jcbfm.2014.205. Epub 2014 Nov 19. J Cereb Blood Flow Metab. 2015. PMID: 25407271 Free PMC article.
-
Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function.J Neurosurg. 2007 Jul;107(1):121-7. doi: 10.3171/JNS-07/07/0121. J Neurosurg. 2007. PMID: 17639881
-
From bench-to-bedside in catastrophic cerebrovascular disease: development of drugs targeting the endothelin axis in subarachnoid hemorrhage-related vasospasm.Neurol Res. 2012 Mar;34(2):195-210. doi: 10.1179/1743132811Y.0000000081. Epub 2012 Feb 2. Neurol Res. 2012. PMID: 22333896 Review.
-
Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.J Neurosurg. 2013 Jul;119(1):180-9. doi: 10.3171/2013.3.JNS121436. Epub 2013 May 3. J Neurosurg. 2013. PMID: 23641823 Review.
Cited by
-
Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.Histol Histopathol. 2021 Feb;36(2):143-158. doi: 10.14670/HH-18-253. Epub 2020 Sep 30. Histol Histopathol. 2021. PMID: 32996580 Review.
-
The Role of Oxidative Stress in Microvascular Disturbances after Experimental Subarachnoid Hemorrhage.Transl Stroke Res. 2019 Dec;10(6):684-694. doi: 10.1007/s12975-018-0685-0. Epub 2019 Jan 9. Transl Stroke Res. 2019. PMID: 30628008
-
Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Delayed Cerebral Ischemia.Front Neurol. 2022 Feb 18;13:817072. doi: 10.3389/fneur.2022.817072. eCollection 2022. Front Neurol. 2022. PMID: 35250821 Free PMC article.
-
Adhesion of Leukocytes to Cerebral Venules Precedes Neuronal Cell Death and Is Sufficient to Trigger Tissue Damage After Cerebral Ischemia.Front Neurol. 2022 Jan 24;12:807658. doi: 10.3389/fneur.2021.807658. eCollection 2021. Front Neurol. 2022. PMID: 35140676 Free PMC article.
-
Clinical Pharmacology of Clazosentan, a Selective Endothelin A Receptor Antagonist for the Prevention and Treatment of aSAH-Related Cerebral Vasospasm.Front Pharmacol. 2021 Feb 4;11:628956. doi: 10.3389/fphar.2020.628956. eCollection 2020. Front Pharmacol. 2021. PMID: 33613288 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical